EQIX three-lens brief
Evidence-based stock research on EQIX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $1198.57 — 15% above current (28 analysts). · P/E of 72 — priced for high growth; little margin of safety.
- P/E of 72 — priced for high growth; little margin of safety.
- Analyst mean target $1198.57 — 15% above current (28 analysts).
- Earnings scheduled 2026-07-29.
EQIX closed at $1039.49 (+0.45%) as of 2026-07-10. Market cap: $102.52B. P/E (trailing) 71.7. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $1198.57 — 15% above current (28 analysts).. Concerns: p/E of 72 — priced for high growth; little margin of safety.. Last quarter: Revenue $2.44B, net income $415.00M, free cash flow $2.73B. Watching for: 2026-07-29 earnings release (18 days out).
Why three lenses on EQIX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine EQIXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/EQIX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath EQIX brief"></iframe>